Institutional members access full text with Ovid®

Share this article on:


Díez-Domingo, Javier MD, PhD*†‡; Martín, Itziar Oyagüez BSc§; Sanz, Alfredo Ballester MD†‡; López, Antonio Gónzalez MD, PhD, MPH§; Martínez, Carmen Casaní MD†∥; Boronat, Carmen Peidró MD†¶; Del Barrio, M Jesús Muñoz MD†¶; García, Dolores Gallego MD†#; Pons, Manuel Martínez MD†#; Crespo, Vicente Antón MD†#; Esteve, Pilar Albors MD†**; Arfella, Inmaculada Latorre MD†**; Monrabal, Ignacio Sorribes MD†††; Baveira, Luis Blesa MD†††; López, Mercedes García MD†‡‡

Pediatric Infectious Disease Journal: May 2006 - Volume 25 - Issue 5 - pp 455-457
doi: 10.1097/01.inf.0000217378.30444.21
Brief Reports

The population-based incidence of rotavirus gastroenteritis in children <5 years of age in Valencia, Spain, over a 1-year period (December 1, 2003, to November 30, 2004) was determined.

A total of 553 episodes of gastroenteritis in children <5 years of age (mean age, 22.8 ± 14.5 months) were recorded (annual incidence of 138 per 1,000). A positive enzyme-linked immunoadsorbant assay result for rotavirus antigen was obtained in 15% of the samples. The incidence of rotavirus gastroenteritis was 15 per 1,000 children <5 years of age, being the highest incidence in children ≤12 months of age (31 per 1,000). Eighty percent of rotavirus gastroenteritis occurred during the winter months (January-March). Genotype G1 was detected in 86% of the samples and G4 in the other 14%.

From the *Vaccine Area, Center for Public Health Research (CSISP); †Vaccine Institute of Valencia (VIVA); ‡C. S. Nazaret; §Medical Department, Sanofi Pasteur MSD, Spain; ∥C. S. Burjassot; ¶C. S. Trafalgar; #C. S. República Argentina; **C. S. Massamagrell; ††C. S. Serrería II; ‡‡C. S. Chile.

Accepted for publication January 19, 2006.

This study was supported by Sanofi Pasteur, MSD, Spain.

Address for correspondence: Dr. Javier Díez-Domingo, Gran Vía Fernando el Católico, 76, E6 izda, Valencia 46008, Spain. E-mail

© 2006 Lippincott Williams & Wilkins, Inc.